The D-FISQ and its variant, the DFIQ, were used among patients with diabetes or kidney failure, as a validated measure of fear of injection and or self-testing associated with insulin or dialysis therapies [29, 34, 36, 42, 45, 46, 53]. The gene discussed is INS; the disease is kidney failure.